Evaluation of Neutrophil–Lymphocyte Ratio as a Prognostic Factor in Cervical Intraepithelial Neoplasia Recurrence
(ندگان)پدیدآور
Farzaneh, FarahFaghih, NafisehHosseini, Maryam SadatArab, MalihehAshrafganjoei, TaherehBahman, Atyehنوع مدرک
TextResearch Articles
زبان مدرک
Englishچکیده
Background: Immune system status is a factor related to cervical intraepithelial neoplasia (CIN) recurrence.neutrophil-lymphocyte ratio (NLR) is a useful factor in assessing the immune status. The aim of this study was toevaluate the prognostic value of NLR factor for CIN recurrence in patient who underwent excisional procedure and itsrelationship with recurrence free survival (RFS). Methods: In this historical cohort study, a population of 307 patientswith CIN (confirmed by excisional pathology) from 2009 to 2017 were selected. NLR and hematologic factors weremeasured before surgery and the follow-up records of these patient were analyzed. The recurrence rate and RFS wereassessed during the follow-up phase. Results: The NLR cut-off point of 1.9 was determined using the Youden Index.NLRUnivariate analysis showed that higher NLR values (Pplatelet lymphocytic ratios (PLR) (P=0.002) were significantly associated with reduction in RFS. The results of Coxregression showed that removing more tissue during excision (HR = 0.325; 95% CI (0.936-0.136) significantly reducedthe hazard of recurrence, higher NLR (HR = 4.55; 95% CI) (1.97-10.51) and white blood cell (WBC) count levels (HR=1.27; 95% CI, 1.04-1.55), significantly decreased RFS, but PLR and ANC associated with RFS were not confirmedby Cox regression. Conclusion: NLR and total WBC count might be prognostic factors involved in the prediction ofrecurrence and RFS in CIN patient underwent excisional procedure. To confirm these results, more prospective studieswith larger sample sizes are needed.
کلید واژگان
cervical intraepithelial neoplasiaRecurrence
Neutrophils
Lymphocytes
Blood Platelets
Gynecologic oncology
شماره نشریه
8تاریخ نشر
2019-08-011398-05-10
ناشر
West Asia Organization for Cancer Prevention (WAOCP)سازمان پدید آورنده
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
شاپا
1513-73682476-762X




